# MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks

> **NCT03824717** · NA · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 55 (estimated)

## Conditions studied

- Infraclavicular Brachial Plexus Block

## Interventions

- **DRUG:** Dose of ropivacaine

## Key facts

- **NCT ID:** NCT03824717
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824717, "MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03824717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*